BIOMAT Database Logo BIOMAT Database Logo

Expression of monoamine oxidase B activity in astrocytes of senile plaques. 1990

S Nakamura, and T Kawamata, and I Akiguchi, and M Kameyama, and N Nakamura, and H Kimura
Department of Neurology, Faculty of Medicine, Kyoto University, Japan.

Monoamine oxidase (MAO) histochemistry has been performed in brains from patients with dementia of Alzheimer type (DAT) and aged controls. Conspicuous MAO-positive cell clusters were frequently observed in the amygdala, hippocampus, and insular cortex in the brains of DAT. Double staining with glial fibrillary acidic protein immunohistochemistry revealed that the cluster-forming MAO-positive cells were astrocytes. Using Bielschowsky's method, Congo red and thioflavin S counterstaining, this astrocytic mass was shown to be associated with senile plaques. By the enzyme inhibition experiment, MAO activity in senile plaques was revealed to be of type B. The present results clearly indicate that MAO-B activity is expressed in fibrillary astrocytes in or around senile plaques, suggesting that these astrocytes metabolize exogenous amines in senile plaques.

UI MeSH Term Description Entries
D008297 Male Males
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003704 Dementia An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. Senile Paranoid Dementia,Amentia,Familial Dementia,Amentias,Dementia, Familial,Dementias,Dementias, Familial,Dementias, Senile Paranoid,Familial Dementias,Paranoid Dementia, Senile,Paranoid Dementias, Senile,Senile Paranoid Dementias
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D001253 Astrocytes A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with MICROGLIA) respond to injury. Astroglia,Astroglia Cells,Astroglial Cells,Astrocyte,Astroglia Cell,Astroglial Cell,Astroglias,Cell, Astroglia,Cell, Astroglial

Related Publications

S Nakamura, and T Kawamata, and I Akiguchi, and M Kameyama, and N Nakamura, and H Kimura
Monoamine oxidase-B in astrocytes.
June 1993, Glia,
S Nakamura, and T Kawamata, and I Akiguchi, and M Kameyama, and N Nakamura, and H Kimura
The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytes.
May 2006, Journal of neural transmission (Vienna, Austria : 1996),
S Nakamura, and T Kawamata, and I Akiguchi, and M Kameyama, and N Nakamura, and H Kimura
Monoamine oxidase B expression is selectively regulated by dexamethasone in cultured rat astrocytes.
March 1996, Brain research,
S Nakamura, and T Kawamata, and I Akiguchi, and M Kameyama, and N Nakamura, and H Kimura
Influence of culture conditions on monoamine oxidase A and B activity in rat astrocytes.
March 1996, Cell biochemistry and function,
S Nakamura, and T Kawamata, and I Akiguchi, and M Kameyama, and N Nakamura, and H Kimura
Amyloid-beta 25-35 peptide induces expression of monoamine oxidase B in cultured rat astrocytes.
June 2000, Acta pharmacologica Sinica,
S Nakamura, and T Kawamata, and I Akiguchi, and M Kameyama, and N Nakamura, and H Kimura
Confocal observation of senile plaques in Alzheimer's disease: senile plaque morphology and relationship between senile plaques and astrocytes.
May 1998, Pathology international,
S Nakamura, and T Kawamata, and I Akiguchi, and M Kameyama, and N Nakamura, and H Kimura
Differential expression of type A and type B monoamine oxidase of mouse astrocytes in primary cultures.
November 1982, Journal of neurochemistry,
S Nakamura, and T Kawamata, and I Akiguchi, and M Kameyama, and N Nakamura, and H Kimura
Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity.
April 2014, Journal of neural transmission (Vienna, Austria : 1996),
S Nakamura, and T Kawamata, and I Akiguchi, and M Kameyama, and N Nakamura, and H Kimura
Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons.
October 1982, Proceedings of the National Academy of Sciences of the United States of America,
S Nakamura, and T Kawamata, and I Akiguchi, and M Kameyama, and N Nakamura, and H Kimura
Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography.
September 1994, Neuroscience,
Copied contents to your clipboard!